Efficacy of an Attentional Process Training Using Competitive Versus Non Competitive Strategies
NCT ID: NCT02220816
Last Updated: 2015-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2014-10-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurofeedback Training of Alpha-band Coherence After Stroke
NCT02223910
Sensorimotor Retraining in Chronic Stroke
NCT03058770
Observational Learning in Stroke Patients
NCT00083642
Focus of Attention in Individuals With Stroke
NCT04696302
Motor Learning in Stroke Patients and Healthy Volunteers
NCT00021710
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Competitive Training
The patients will receive only competitive activities designed to restore attention abilities. These include pencil-and-paper tasks completed under competitive circumstances and competitive virtual games specifically designed to treat different aspects of attention (divided, selective, sustained, etc).
Competitive training
30 sessions of competitive cognitive training; 3 - 5 sessions/week; duration 45 min
Non-Competitive Training
The patients will receive conventional attentional training. Pencil and paper tasks focused on different aspects of attention (divided, selective, sustained, etc.) will be completed by all participant under individual or group-therapy sessions. No competitive training will be allowed.
Non-Competitive Training
30 sessions of non-competitive cognitive training; 3 - 5 sessions/week; duration 45 min
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Competitive training
30 sessions of competitive cognitive training; 3 - 5 sessions/week; duration 45 min
Non-Competitive Training
30 sessions of non-competitive cognitive training; 3 - 5 sessions/week; duration 45 min
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronicity \> 6 months
* More than 3 months under cognitive rehabilitation
* Mississippi Aphasia Screening Test (comprehension subtest \> 45)
Exclusion Criteria
* Unable to give informed consent
* Visual or auditive disorders limiting the ability to comply with treatment regimen
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitat Politècnica de València
OTHER
University of Seville
OTHER
Hospitales Nisa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roberto Llorens, PhD
Role: PRINCIPAL_INVESTIGATOR
Universitat Politècnica de València
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospitales NISA
Valencia, Valencia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NISA-COG-2014/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.